title: Effects of microparticle size and Fc density on macrophage phagocytosis.
abstract: Controlled induction of phagocytosis in macrophages offers the ability to therapeutically regulate the immune system as well as improve delivery of chemicals or biologicals for immune processing. Maximizing particle uptake by macrophages through Fc receptor-mediated phagocytosis could lead to new delivery mechanisms in drug or vaccine development. Fc ligand density and particle size were examined independently and in combination in order to optimize and tune the phagocytosis of opsonized microparticles. We show the internalization efficiency of small polystyrene particles (0.5 µm to 2 µm) is significantly affected by changes in Fc ligand density, while particles greater than 2 µm show little correlation between internalization and Fc density. We found that while macrophages can efficiently phagocytose a large number of smaller particles, the total volume of phagocytosed particles is maximized through the non-specific uptake of larger microparticles. Therefore, larger microparticles may be more efficient at delivering a greater therapeutic payload to macrophages, but smaller opsonized microparticles can deliver bio-active substances to a greater percentage of the macrophage population. This study is the first to treat as independent variables the physical and biological properties of Fc density and microparticle size that initiate macrophage phagocytosis. Defining the physical and biological parameters that affect phagocytosis efficiency will lead to improved methods of microparticle delivery to macrophages.
authors: George W. Woodruff School of Mechanical Engineering, Parker H. Petit Institute for Bioengineering and Bioscience, Georgia Institute of Technology, Atlanta, Georgia, United States of America.
authors: Patricia
authors: P
authors: Pacheco
authors: David
authors: D
authors: White
authors: Todd
authors: T
authors: Sulchek
mesh_terms: D000818:Animals; D002460:Cell Line; D004337:Drug Carriers / Q000737:chemistry / Q000378:metabolism; D007141:Immunoglobulin Fc Fragments / Q000737:chemistry* / Q000378:metabolism; D008264:Macrophages / Q000502:physiology*; D051379:Mice; D008863:Microspheres; D009895:Opsonin Proteins / Q000737:chemistry / Q000378:metabolism; D010316:Particle Size; D010587:Phagocytosis; D011137:Polystyrenes / Q000737:chemistry / Q000378:metabolism; D011961:Receptors, Fc / Q000378:metabolism*
chemical_list: D004337:Drug Carriers; D007141:Immunoglobulin Fc Fragments; D009895:Opsonin Proteins; D011137:Polystyrenes; D011961:Receptors, Fc
references: Annu Rev Immunol. 2000;18:709-37
references: 10837073
references: Trends Immunol. 2006 Dec;27(12):573-9
references: 17049307
references: J Exp Med. 1999 May 3;189(9):1497-506
references: 10224290
references: Immunol Lett. 2010 Oct 30;133(2):70-7
references: 20670655
references: Annu Rev Immunol. 1995;13:251-76
references: 7612223
references: Pharm Res. 2008 Aug;25(8):1815-21
references: 18373181
references: PLoS Comput Biol. 2011 Jan 27;7(1):e1001068
references: 21298079
references: J Pharm Pharm Sci. 2000 May-Aug;3(2):234-58
references: 10994037
references: Nat Rev Immunol. 2005 Dec;5(12):953-64
references: 16322748
references: J Leukoc Biol. 2004 Dec;76(6):1093-103
references: 15466916
references: J Control Release. 2002 Feb 19;79(1-3):29-40
references: 11853916
references: J Biol Chem. 1999 Jan 15;274(3):1240-7
references: 9880492
references: J Exp Med. 2001 Jan 1;193(1):61-71
references: 11136821
references: Annu Rev Immunol. 2002;20:825-52
references: 11861619
references: Biomaterials. 1988 Jul;9(4):356-62
references: 3214660
references: Nature. 1996 Oct 31;383(6603):787-93
references: 8893001
references: Eur Respir J. 2006 Sep;28(3):486-95
references: 16737992
references: Adv Mater. 2009;21:419-424
references: 19606281
references: Proc Natl Acad Sci U S A. 2005 Jul 5;102(27):9469-74
references: 15972807
references: Biomaterials. 2007 Jun;28(18):2915-22
references: 17363051
references: Curr Opin Immunol. 2001 Feb;13(1):114-9
references: 11154927
references: Biotechnol Bioeng. 2007 Feb 1;96(2):203-9
references: 17191251
references: Proc Natl Acad Sci U S A. 2006 Mar 28;103(13):4930-4
references: 16549762
references: Vaccine. 2009 May 18;27(23):3013-21
references: 19428913
references: Annu Rev Immunol. 1999;17:593-623
references: 10358769
references: Nat Mater. 2009 Jan;8(1):15-23
references: 19096389
references: J Immunol. 2002 Apr 15;168(8):3697-701
references: 11937518
references: PLoS One. 2009 Jun 26;4(6):e6056
references: 19557127
references: BMC Syst Biol. 2010 Nov 08;4:149
references: 21059234
references: J Exp Med. 1997 Jun 2;185(11):1977-85
references: 9166427
references: Science. 1982 Jan 1;215(4528):64-6
references: 7053559
references: Lancet Oncol. 2004 May;5(5):292-302
references: 15120666
references: J Control Release. 2001 Mar 12;71(1):39-51
references: 11245907
references: Annu Rev Immunol. 1989;7:145-73
references: 2523712
references: Angew Chem Int Ed Engl. 1998 Nov 2;37(20):2754-2794
references: 29711117
references: J Cell Sci. 2006 May 1;119(Pt 9):1903-13
references: 16636075
references: Cancer Res. 2001 May 15;61(10):4061-5
references: 11358826
references: Annu Rev Immunol. 2001;19:275-90
references: 11244038
references: J Immunol. 1995 Jul 1;155(1):367-76
references: 7541421
references: Proc Natl Acad Sci U S A. 2010 Nov 9;107(45):19332-7
references: 20974965